Sector: Biotech / Longevity
Platform: Wefunder
Valuation: $8M cap
Minimum Investment: $250
What They Do
Vampire Corp is pioneering anti-aging and regenerative medicine therapies by leveraging cutting-edge blood plasma technology.
Why It Might Be the Next Big Thing
The global anti-aging market is projected to hit $88 billion by 2026. Vampire Corp’s innovations target core aging processes, positioning them at the forefront of longevity breakthroughs.
Who’s Backing Them
Exclusive rights acquired from Vampire Family Brands, LLC, known for the VAMPIRE trademark in wine, spirits, and more.
Snapshot
🧬 Biotech meets plasma science
📈 Rapid market expansion expected
💡 Founder team with deep biotech experience
My Take
Longevity tech is the next gold rush—and Vampire Corp could be an early winner. Their IP position and experienced team offer a promising head start in a booming sector.